Is your child currently experiencing CD flare-ups? Local clinical research is testing a potential new medication to see if it may reduce abdominal pain or cramping, perianal fistula, bloody stool, malnutrition, and/or anemia associated with CD.
If you’re concerned about how CD affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for children and teens 2–17 years of age to join a Crohn’s disease (CD) trial to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or Crohn’s (including associated symptoms such as recurrent diarrhea, stomach pain, abdominal pain, malnutrition and/or joint pain), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local clinical research is testing a potential new medication to see if it may reduce chronic diarrhea, fatigue, abdominal pain, chronic fatigue, and/or anemia associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for young people 2–17 years of age to join a CD clinical research to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or moderately to severely active ulcerative colitis (including associated symptoms such as fatigue, kidney stones, bloody stool, weight loss and/or joint pain), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing Crohn’s and UC flare-ups? Local Crohn’s disease (CD) clinical research study is testing a potential new medication to see if it may reduce joint pain, joint pain, diarrhea, chronic fatigue, and/or joint pain associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the Crohn’s disease (CD) clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for teen to join a clinical research study to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or ulcerative colitis (UC) (including associated symptoms such as tiredness, diarrhea, diarrhea, malnutrition and/or liver disease), consider one of our ICD and UC clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your teen may be eligible to take part.

Your child may be eligible to take part in the ICD and UC clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing moderate to severe IBD flare-ups? Local CD clinical research is testing a potential new medication to see if it may reduce abdominal pain and cramps, persistent diarrhea, abdominal pain, chronic fatigue, and/or joint pain associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the CD clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for 2 to 17 years of age to join a CD clinical research to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or CD and UC (including associated symptoms such as swollen joints, joint pain, rectal pain, malnutrition and/or liver disease), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing moderate to severe Crohn’s disease flare-ups? Local Crohn’s disease (CD) trial is testing a potential new medication to see if it may reduce diarrhea with pus, fatigue, rectal pain, frequent fevers, and/or anemia associated with moderate to severe Crohn’s disease.
If you’re concerned about how moderate to severe Crohn’s disease affects your child’s life, find out more about the Crohn’s disease (CD) trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.

We are looking for 2–17 year olds to join a Crohn’s disease (CD) research study to help us discover more about treating CD. If you are looking for a potential new treatment option for CD or moderate to severe UC (including associated symptoms such as chronic diarrhea, growth failure, diarrhea, malnutrition and/or liver disease), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.